Medicare Enrolled
Dr. Alan Rodney, MD
Hematology & Oncology · Webster, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rodney from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rodney?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rodney
Dr. Alan Rodney is a hematology & oncology specialist in Webster, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rodney performed 36,838 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Rodney received a total of $495,872 from 71 pharmaceutical and/or device companies across 863 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rodney is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 26% volume in TX
$495,872 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗36,838
Medicare services
Top 26% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
26,010 | $0 | $5 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
5,900 | $0 | $2 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,083 | $0 | $3 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
586 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
579 | $7 | $36 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
254 | $10 | $64 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
245 | $95 | $368 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
194 | $69 | $250 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
157 | $8 | $49 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
146 | $6 | $31 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
121 | $7 | $431 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
111 | $51 | $313 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
76 | $5 | $26 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
75 | $34 | $143 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
59 | $91 | $357 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
53 | $11 | $96 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
43 | $102 | $707 |
| Liver function blood test panel | 36 | $7 | $48 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
21 | $130 | $565 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
18 | $56 | $821 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $90 | $372 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
15 | $97 | $470 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
14 | $187 | $1,067 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
12 | $23 | $157 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 12 | $90 | $657 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
71.1% high complexity
22.2% medium
6.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$495,872
Total received (2018-2024)
Avg $70,839/year across 7 years
Top 1% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
863
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$80,072
2023
$68,862
2022
$91,924
2021
$16,257
2020
$29,475
2019
$117,791
2018
$91,492
Payments by company (2024)
Merck Sharp & Dohme LLC
$30,371
PharmaEssentia USA Corporation
$23,429
E.R. Squibb & Sons, L.L.C.
$15,265
AstraZeneca Pharmaceuticals LP
$7,467
Astellas Pharma US Inc
$972
GlaxoSmithKline, LLC.
$388
Celgene Corporation
$287
Incyte Corporation
$254
Regeneron Healthcare Solutions, Inc.
$239
PFIZER INC.
$162
Gilead Sciences, Inc.
$158
Janssen Biotech, Inc.
$158
Apellis Pharmaceuticals, Inc.
$130
Genmab U.S., Inc.
$125
Takeda Pharmaceuticals U.S.A., Inc.
$122
Novartis Pharmaceuticals Corporation
$90
ARRAY BIOPHARMA INC
$66
TAIHO ONCOLOGY, INC.
$47
Eisai Inc.
$43
SpringWorks Therapeutics, Inc.
$42
Lilly USA, LLC
$32
BeiGene USA, Inc.
$24
GENZYME CORPORATION
$23
SOBI, INC
$22
ABBVIE INC.
$22
Aveo Pharmaceuticals, Inc.
$22
Mirati Therapeutics, Inc.
$22
ImmunoGen, Inc.
$20
Exelixis Inc.
$19
EMD Serono, Inc.
$17
PUMA BIOTECHNOLOGY, INC.
$17
Myriad Genetic Laboratories, Inc.
$16
Top 3 companies account for 86.3% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$239,872
Takeda Pharmaceuticals U.S.A., Inc.
$63,549
PharmaEssentia USA Corporation
$54,892
Astellas Pharma US Inc
$31,804
Merck Sharp & Dohme LLC
$30,635
Celgene Corporation
$26,380
AstraZeneca Pharmaceuticals LP
$12,336
Gilead Sciences, Inc.
$6,833
PFIZER INC.
$6,747
Novartis Pharmaceuticals Corporation
$5,321
Kite Pharma, Inc.
$3,898
Seattle Genetics, Inc.
$2,904
Incyte Corporation
$1,359
GlaxoSmithKline, LLC.
$1,322
Seagen Inc.
$783
BeiGene USA, Inc.
$663
Amgen Inc.
$546
MENARINI SILICON BIOSYSTEMS, INC.
$473
Daiichi Sankyo Inc.
$463
GENZYME CORPORATION
$426
Regeneron Healthcare Solutions, Inc.
$334
Janssen Biotech, Inc.
$330
Lilly USA, LLC
$311
Exelixis Inc.
$259
Genmab U.S., Inc.
$250
TESARO, Inc.
$247
Eisai Inc.
$192
Genentech USA, Inc.
$191
Mirati Therapeutics, Inc.
$185
Karyopharm Therapeutics Inc.
$165
Bayer HealthCare Pharmaceuticals Inc.
$160
Pharmacosmos Therapeutics Inc.
$154
Apellis Pharmaceuticals, Inc.
$152
EISAI INC.
$129
G1 Therapeutics, Inc.
$119
Ipsen Biopharmaceuticals, Inc
$117
Merck Sharp & Dohme Corporation
$104
Pharmacyclics LLC, An AbbVie Company
$97
MorphoSys, US Inc.
$78
AVEO Pharmaceuticals, Inc.
$75
SANOFI-AVENTIS U.S. LLC
$75
ARRAY BIOPHARMA INC
$66
TAIHO ONCOLOGY, INC.
$64
Boehringer Ingelheim Pharmaceuticals, Inc.
$61
Kyowa Kirin, Inc.
$54
SOBI, INC
$51
Sobi, Inc
$47
Pharmacyclics LLC, an AbbVie Company
$44
EMD Serono, Inc.
$44
SpringWorks Therapeutics, Inc.
$42
Puma Biotechnology, Inc.
$40
ABBVIE INC.
$39
CTI BioPharma Corp.
$33
TerSera Therapeutics LLC
$28
JAZZ PHARMACEUTICALS INC.
$26
Deciphera Pharmaceuticals Inc.
$26
Bayer Healthcare Pharmaceuticals Inc.
$23
ADC Therapeutics America, Inc.
$22
Aveo Pharmaceuticals, Inc.
$22
Sirtex Medical Inc
$20
ImmunoGen, Inc.
$20
Pharming Healthcare, Inc.
$20
Mylan Institutional Inc.
$19
Rigel Pharmaceuticals, Inc.
$19
Blueprint Medicines Corporation
$19
Taiho Oncology, Inc.
$18
Adaptive Biotechnologies Corporation
$17
PUMA BIOTECHNOLOGY, INC.
$17
Myriad Genetic Laboratories, Inc.
$16
Sun Pharmaceutical Industries Inc.
$14
Clovis Oncology, Inc.
$11
Top 3 companies account for 72.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · Adcetris · Alecensa · Aranesp · BESPONSA · BESREMI · BLENREP · BOSULIF · BRACANALYSIS CDX · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · COSELA · Cabometyx · Cellsearch · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · ERLEADA · Empaveli · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · GAZYVA · GILOTRIF · GLEEVEC · IBRANCE · ILARIS · IMBRUVICA · IMFINZI · INLYTA · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · NINLARO · Nplate · OGIVRI · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · PADCEV · PIQRAY · POTELIGEO · PROMACTA · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RUCONEST · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · Stivarga · TABRECTA · TAFINLAR · TAGRISSO · TALVEY · TECENTRIQ · TUKYSA · Tazverik · Trodelvy · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vonjo · WELIREG · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONSA · ZEJULA · ZEPZELCA · Zoladex · Zydelig · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
180
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
HCA HOUSTON HEALTHCARE CLEAR LAKE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rodney is a mixed practice specialist, with above-average Medicare volume (top 26% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rodney experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Rodney performed 26,010 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rodney receive payments from pharmaceutical companies?
Yes. Dr. Rodney received a total of $495,872 from 71 companies across 863 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rodney's costs compare to other hematology & oncology specialists in Webster?
Dr. Rodney's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rodney) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Webster
Browse hematology & oncology specialists in Webster ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
PharmaEssentia USA Corporation Payments to Doctors
See all physicians who received payments from PharmaEssentia USA Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology